Terms: = Kidney tumors AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Staging
660 results:
1. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
[TBL] [Abstract] [Full Text] [Related]
2. Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia.
Puliatti S; Ferretti S; Peñaranda NR; Eissa A; Ticonosco M; De Faveri A; De Carne C; Wisz P; Ferrari R; Tosi G; Annino F; Bianchi G; Micali S
Int Braz J Urol; 2024; 50(2):227-228. PubMed ID: 38386794
[TBL] [Abstract] [Full Text] [Related]
3. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal.
Rezaee ME; Pallauf M; Fletcher SA; Pavlovich CP; Baraban E; Ged Y; Singla N
Urol Oncol; 2024 Apr; 42(4):119.e23-119.e29. PubMed ID: 38355353
[TBL] [Abstract] [Full Text] [Related]
5. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
6. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
Saitta C; Afari JA; Walia A; Patil D; Tanaka H; Hakimi K; Wang L; Meagher MF; Liu F; Nguyen MV; Puri D; Cerrato C; Saidian A; Kobayashi M; Fukuda S; Fujii Y; Master V; Derweesh IH
Urol Oncol; 2024 Apr; 42(4):119.e1-119.e16. PubMed ID: 38341362
[TBL] [Abstract] [Full Text] [Related]
7. Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
Singhal T; Singh P; Parida GK; Agrawal K
Ann Nucl Med; 2024 Mar; 38(3):176-187. PubMed ID: 38340144
[TBL] [Abstract] [Full Text] [Related]
8. Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" Score.
Ishiyama Y; Omae K; Kondo T; Yoshida K; Iizuka J; Takagi T
Ann Surg Oncol; 2024 May; 31(5):3513-3522. PubMed ID: 38285306
[TBL] [Abstract] [Full Text] [Related]
9. Congenital Mesoblastic Nephroma Mimic Wilms Tumor on 18 F-FDG PET/CT and PET/MR.
Hu W; Qin C; Shao F; Li M; Lan X
Clin Nucl Med; 2024 Apr; 49(4):353-355. PubMed ID: 38271261
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey.
Liedberg F; Hagberg O; Aljabery F; Gårdmark T; Jahnson S; Jerlström T; Ströck V; Söderkvist K; Ullén A; Bobjer J
Scand J Urol; 2024 Jan; 59():19-25. PubMed ID: 38226846
[TBL] [Abstract] [Full Text] [Related]
11. The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
Nakano J; Urabe F; Kiuchi Y; Takamizawa S; Suzuki H; Kawano S; Miyajima K; Fukuokaya W; Takahashi K; Iwatani K; Imai Y; Kayano S; Aikawa K; Yanagisawa T; Tashiro K; Yuen S; Sato S; Tsuzuki S; Miki J; Kimura T;
Int J Urol; 2024 Apr; 31(4):394-401. PubMed ID: 38151321
[TBL] [Abstract] [Full Text] [Related]
12. Single-Port Robotic Radical Prostatectomy Using Transvesical and Transperineal Access in Patients with a Hostile Abdomen.
Ferguson EL; Ramos-Carpinteyro R; Soputro N; Chavali JS; Geskin A; Kaouk JH
J Endourol; 2024 Feb; 38(2):150-158. PubMed ID: 38069569
[No Abstract] [Full Text] [Related]
13. FDG PET/CT in Solitary Isolated Renal Metastasis From Squamous Cell Lung Cancer.
Zhang J; Dong A; Wang Y
Clin Nucl Med; 2024 Feb; 49(2):e50-e51. PubMed ID: 38048520
[TBL] [Abstract] [Full Text] [Related]
14. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.
Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG
J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic impact of pre-referral tumor resection in unilateral Wilms tumor: A single-institute experience from a lower middle-income country.
Khan MS; Maaz AUR; Qazi AQ; Aslam S; Riaz S; Malik AS; Shaheen N
Pediatr Blood Cancer; 2024 Feb; 71(2):e30760. PubMed ID: 37962283
[TBL] [Abstract] [Full Text] [Related]
16. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
[TBL] [Abstract] [Full Text] [Related]
17. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
18. Spatio-temporal heterogeneity in cancer evolution and tumor microenvironment of renal cell carcinoma with tumor thrombus.
Zhou S; Zheng J; Zhai W; Chen Y
Cancer Lett; 2023 Sep; 572():216350. PubMed ID: 37574183
[TBL] [Abstract] [Full Text] [Related]
19. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
[TBL] [Abstract] [Full Text] [Related]
20. Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma.
Saal J; Bald T; Eckstein M; Ralser DJ; Ritter M; Brossart P; Grünwald V; Hölzel M; Ellinger J; Klümper N
JAMA Oncol; 2023 Aug; 9(8):1048-1055. PubMed ID: 37347489
[TBL] [Abstract] [Full Text] [Related]
[Next]
